Paper Review Records
All Paper Review Records
16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
3
days
Rethinking Progression in Hepatocellular Carcinoma: Is Oligoprogression a Window for Local Ablation?
AuthorsHisashi Hidaka
Affiliations1. Department of Gastroenterology Internal Medicine Kitasato University School of Medicine Sagamihara Kanagawa Japan
104
days
Immunotherapy‐Facilitated Conversion Surgery for Biliary Tract Cancer: A Case Series of Long‐Term Survivors Following Durvalumab Combined With Gemcitabine and Cisplatin
AuthorsShinichiro Hasegawa; Hiroshi Wada; Ryoji Takada; Masahiko Kubo; Masahiro Umezu; Shigenori Nagata; Keiichiro Honma; Yasunari Fukuda; Hisateru Komatsu; Kunihito Gotoh; Kei Yamamoto; Ryota Mori; Masatoshi Kitakaze; Norihiro Matsuura; Yasunori Masuike; Takahito Sugase; Yuki Ushimaru; Masaaki Miyo; Yoshitomo Yanagimoto; Takashi Kanemura; Toshinori Sueda; Yoshinori Kagawa; Kazuyoshi Yamamoto; Junichi Nishimura; Hiroshi Miyata; Masayuki Ohue; Shogo Kobayashi
Affiliations1. Department of Gastroenterological Surgery Osaka International Cancer Institute Osaka Japan; 2. Department of Hepato‐Biliary‐Pancreatic Oncology Osaka International Cancer Institute Osaka Japan; 3. Department of Gastroenterological Surgery The University of Osaka Osaka Japan; 4. Department of Pathology Osaka International Cancer Institute Osaka Japan
89
days
Serum Mac‐2 Binding Protein Glycan Isomer and Cerebral White Matter Injury in Older Adults: A Hepatic–Cerebral Link
AuthorsMaiko Nagaoka; Katsuya Nagaoka; Naoto Kajitani; Yoko Yoshimaru; Takehisa Watanabe; Hiroko Setoyama; Hirofumi Soejima; Noboru Fujise; Minoru Takebayashi; Manabu Makinodan; Yasuhito Tanaka
Affiliations1. Health Care Center Kumamoto University Kumamoto Japan; 2. Department of Gastroenterology and Hepatology, Faculty of Life Sciences Kumamoto University Kumamoto Japan; 3. Department of Psychiatry and Neuroscience, Center for Metabolic Regulation of Healthy Aging, Faculty of Life Sciences Kumamoto University Kumamoto Japan; 4. Mental Wellness Support Center Kumamoto University Hospital Kumamoto Japan; 5. Department of Neuropsychiatry, Faculty of Life Sciences Kumamoto University Kumamoto Japan
337
days
FOXS1 Promotes Liver Fibrosis Through TGF‐β1/Smad Signaling: Targeting a Novel miR‐212‐5p/FTO Axis
AuthorsMaoqun Zhu; Tong Zhang; Xiang Wang; Benshun Hu; Bingyi Dai; Baoyang Luo; Xinyi Xu; Donglin Sun; Xiaodong Xu
Affiliations1. Department of Hepatobiliary and Pancreatic Surgery Affiliated Hospital of Jiangnan University Wuxi Jiangsu China; 2. Department of Hepatobiliary Surgery Xinghua City People's Hospital Affiliated to Yangzhou University Taizhou Jiangsu China; 3. Department of Otolaryngology Affiliated Hospital of Jiangnan University Wuxi Jiangsu China; 4. Department of Hepatobiliary Surgery Taizhou People's Hospital Taizhou Jiangsu China; 5. Department of Institute of Translational Medicine Affiliated Hospital of Jiangnan University Wuxi Jiangsu China; 6. Department of Hepatobiliary and Pancreatic Surgery Third Affiliated Hospital of Soochow University Changzhou Jiangsu China; 7. Department of General Surgery Yancheng Clinical Medical College of Jiangsu University, The First People's Hospital of Yancheng Yancheng Jiangsu China
132
days
Compensatory Hepatic Hypertrophy After Carbon Ion Radiotherapy for Hepatocellular Carcinoma: Factors Associated With Its Development and Relationship With Prognosis
AuthorsTatsuma Murakami; Takeshi Hatanaka; Yumeo Tateyama; Hiroki Tojima; Yuichi Yamazaki; Yuhei Miyasaka; Kei Shibuya; Atsushi Naganuma; Satoru Kakizaki; Tatsuya Ohno; Toshio Uraoka
Affiliations1. Department of Gastroenterology and Hepatology Gunma University Graduate School of Medicine Maebashi Japan; 2. Department of Gastroenterology Gunma Saiseikai Maebashi Hospital Maebashi Japan; 3. Department of Radiation Oncology Gunma University Graduate School of Medicine Maebashi Japan; 4. Department of Gastroenterology NHO Takasaki General Medical Center Takasaki Japan; 5. Department of Clinical Research NHO Takasaki General Medical Center Takasaki Japan
86
days
Evolving Strategies in HBV Management: Insights From Updated International Guidelines
AuthorsMasaru Enomoto; Grace Lai‐Hung Wong; Rui Huang; Mindie H. Nguyen
Affiliations1. Department of Hepatology Osaka Metropolitan University Graduate School of Medicine Osaka Japan; 2. Department of Gastroenterology Osaka City General Hospital Osaka Japan; 3. Department of Medicine and Therapeutics The Chinese University of Hong Kong Hong Kong China; 4. Division of Gastroenterology and Hepatology Department of Medicine Stanford University Medical Center Palo Alto California USA; 5. Department of Infectious Diseases Nanjing Drum Tower Hospital Affiliated Hospital of Medical School Nanjing University Nanjing China; 6. Department of Epidemiology and Population Health Stanford University Stanford California USA
41
days
Tumor Mutational Concordance and Recurrence Timing in Hepatocellular Carcinoma
AuthorsYuya Miura; Ryo Ashida; Keiichi Ohshima; Yukiyasu Okamura; Takeshi Nagashima; Keiichi Hatakeyama; Teiichi Sugiura; Katsuhisa Ohgi; Shimpei Otsuka; Hideyuki Dei; Yuko Kakuda; Takuma Oishi; Kenichi Urakami; Yasuto Akiyama; Katsuhiko Uesaka; Ken Yamaguchi
Affiliations1. Division of Hepato‐Biliary‐Pancreatic Surgery Shizuoka Cancer Center Shizuoka Japan; 2. Division of Digestive Surgery, Department of Surgery Nihon University School of Medicine Tokyo Japan; 3. Department of Gastroenterological Surgery Shizuoka General Hospital Shizuoka Japan; 4. Medical Genetics Division Shizuoka Cancer Center Research Institute Shizuoka Japan; 5. Cancer Diagnostics Research Division Shizuoka Cancer Center Research Institute Shizuoka Japan; 6. SRL, Inc. Tokyo Japan; 7. Cancer Multiomics Division Shizuoka Cancer Center Research Institute Shizuoka Japan; 8. Division of Pathology Shizuoka Cancer Center Shizuoka Japan; 9. Immunotherapy Division Shizuoka Cancer Center Research Institute Shizuoka Japan; 10. Shizuoka Cancer Center Shizuoka Japan
5
days
Evidence‐Based Clinical Practice Guidelines for Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) 2026
AuthorsNorio Akuta; Tomomi Kogiso; Kenichi Ikejima; Motoyuki Otsuka; Takumi Kawaguchi; Miwa Kawanaka; Hirokazu Takahashi; Nobuharu Tamaki; Hayato Nakagawa; Hayato Hikita; Hideki Fujii; Kanji Yamaguchi; Masato Yoneda; Kazuyoshi Kon; Akira Uchiyama; Yuya Seko; Sadatsugu Sakane; Ryuta Shigefuku; Naoto Fujiwara; Michihiro Iwaki; Takashi Kobayashi; Takuya Adachi; Yasuto Takeuchi; Tsubasa Tsutsumi; Dan Nakano; Kaoru Shibayama; Noriyo Urata; Hisamitsu Miyaaki; Hidekatsu Kuroda; Masahiro Koseki; Hirohito Sone; Yasuhiro Matsubayashi; Keisuke Kakisaka; Atsushi Takai; Kazuo Notsumata; Masataka Seike; Yoshiyuki Takei; Yoshifumi Takeyama; Susumu Eguchi; Sumio Watanabe; Hajime Isomoto; Hiroshi Yotsuyanagi; Takao Itoi; Tetsuo Takehara; Satoshi Mochida
Affiliations1. Guidelines Committee for Creating and Evaluating the “Evidence‐Based Clinical Practice Guidelines for Metabolic Dysfunction‐Associated Steatotic Liver Disease 2026 (3rd Edition)” The Japanese Society of Gastroenterology/The Japan Society of Hepatology Tokyo Japan; 2. Department of Hepatology Toranomon Hospital 2‐2‐2 Tokyo Japan; 3. Department of Internal Medicine Institute of Gastroenterology, Tokyo Women’s Medical University 8‐1 Tokyo Japan; 4. The Japan Society of Hepatology Tokyo Japan
28
days
Ablation‐Based Salvage Strategy at Disease Progression After Initial Disease Control With Atezolizumab/Bevacizumab in Hepatocellular Carcinoma
AuthorsKazuya Kariyama; Kazuhiro Nouso; Atsushi Hiraoka; Fujimasa Tada; Hideko Ohama; Hidenori Toyoda; Satoshi Yasuda; Toshifumi Tada; Kazunari Tanaka; Kunihiko Tsuji; Ei Itobayashi; Akemi Tsutsui; Koichi Takaguchi; Michitaka Imai; Toru Ishikawa; Takeshi Hatanaka; Yuki Kanayama; Satoru Kakizaki; Atsushi Naganuma; Yoshihide Ueda; Tomomitsu Matono; Hideyuki Tamai; Junpei Okamura; Hironori Tanaka; Yutaka Yata; Akiko Wakuta; Masatoshi Kudo; Takashi Kumada
Affiliations1. Department of Gastroenterology Okayama City Hospital Okayama Japan; 2. Gastroenterology Center Ehime Prefectural Central Hospital Matsuyama Japan; 3. Department of Gastroenterology and Hepatology Ogaki Municipal Hospital Ogaki Japan; 4. Department of Internal Medicine Division of Gastroenterology Kobe University Graduate School of Medicine Kobe Japan; 5. Center for Gastroenterology Teine Keijinkai Hospital Sapporo Japan; 6. Department of Gastroenterology Asahi General Hospital Asahi Japan; 7. Department of Hepatology Kagawa Prefectural Central Hospital Takamatsu Japan; 8. Department of Internal Medicine Niigata Cancer Center Hospital Niigata Japan; 9. Department of Gastroenterology Saiseikai Niigata Hospital Niigata Japan; 10. Department of Gastroenterology Gunma Saiseikai Maebashi Hospital Maebashi Japan; 11. Department of Clinical Research NHO Takasaki General Medical Center Takasaki Japan; 12. Department of Gastroenterology NHO Takasaki General Medical Center Takasaki Japan; 13. Department of Gastroenterology Kakogawa City Hospital Kakogawa Japan; 14. Department of Gastroenterology Hyogo Prefectural Harima‐Himeji General Medical Center Himeji Japan; 15. Department of Hepatology Wakayama Rosai Hospital Wakayama Japan; 16. Department of Gastroenterology Takarazuka City Hospital Takarazuka Hyogo Japan; 17. Department of Gastroenterology Hanwa Memorial Hospital Osaka Japan; 18. Department of Gastroenterology and Hepatology Faculty of Medicine Kindai University Osaka Japan; 19. Department of Nursing Gifu Kyoritsu University Ogaki Japan
128
days
Widespread Muscle Loss in Autoimmune Hepatitis and Its Adverse Prognostic Impact
AuthorsTomoko Tadokoro; Asahiro Morishita; Takushi Manabe; Hiroki Tai; Rie Yano; Mai Nakahara; Kyoko Oura; Koji Fujita; Shima Mimura; Joji Tani; Hideki Kobara
Affiliations1. Department of Gastroenterology and Neurology, Faculty of Medicine Kagawa University Kagawa Japan; 2. Department of Gastroenterology and Hepatology Takamatsu Red Cross Hospital Takamatsu Japan
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days